Copy to clipboard 
ConMed posted 2Q18 arthroscopy/soft tissue repair revenue of US $110.1MM, +4.3% vs. 2Q17, and 1H18 revenue of $219.0MM, +3.7% vs. 1H17.
| 2Q18 | 2Q17 | $ Change | % Change | |
| Arthroscopy/Soft Tissue Repair | $110.1 | $105.6 | $4.5 | 4.3% |
| 1H18 | 1H17 | $ Change | % Change | |
| Arthroscopy/Soft Tissue Repair | $219.0 | $209.4 | $9.6 | 4.6% |
Revenue by geographic region:
| 2Q18 | 1H18 | |
| U.S. | $41.0 | $84.2 |
| Ex-U.S. | $69.0 | $134.7 |
For 2Q18, domestic ortho sales grew 2.1% year over year, and international increased 3.2%. This represents the third and the ninth consecutive quarters of growth for these geographic regions. International sales are expected to lift in 2H18 as new product launches begin.
While products shown at AAOS are still contributing to growth, leadership reminded us to expect more new products later in the year. You’ll recall that CNMD’s portfolio was incomplete and dated for many years, and is now refreshed with the Hall MicroFree cordless power handpiece, ExoShape soft tissue fasteners, new longer probes for hip arthroscopy with the Edge Bipolar Arthroscopic RF System, etc. New products and revamped marketing/R&D teams continue to support the turnaround.
Source: ConMed Corporation
ConMed posted 2Q18 arthroscopy/soft tissue repair revenue of US $110.1MM, +4.3% vs. 2Q17, and 1H18 revenue of $219.0MM, +3.7% vs. 1H17.
Q18
Q17
$ Change
% Change
Arthroscopy/Soft Tissue Repair
$110.1 ...
ConMed posted 2Q18 arthroscopy/soft tissue repair revenue of US $110.1MM, +4.3% vs. 2Q17, and 1H18 revenue of $219.0MM, +3.7% vs. 1H17.
| 2Q18 | 2Q17 | $ Change | % Change | |
| Arthroscopy/Soft Tissue Repair | $110.1 | $105.6 | $4.5 | 4.3% |
| 1H18 | 1H17 | $ Change | % Change | |
| Arthroscopy/Soft Tissue Repair | $219.0 | $209.4 | $9.6 | 4.6% |
Revenue by geographic region:
| 2Q18 | 1H18 | |
| U.S. | $41.0 | $84.2 |
| Ex-U.S. | $69.0 | $134.7 |
For 2Q18, domestic ortho sales grew 2.1% year over year, and international increased 3.2%. This represents the third and the ninth consecutive quarters of growth for these geographic regions. International sales are expected to lift in 2H18 as new product launches begin.
While products shown at AAOS are still contributing to growth, leadership reminded us to expect more new products later in the year. You’ll recall that CNMD’s portfolio was incomplete and dated for many years, and is now refreshed with the Hall MicroFree cordless power handpiece, ExoShape soft tissue fasteners, new longer probes for hip arthroscopy with the Edge Bipolar Arthroscopic RF System, etc. New products and revamped marketing/R&D teams continue to support the turnaround.
Source: ConMed Corporation
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.
